Celularity Analyst Ratings

Celularity 分析师评级

Date	Upside/Downside	Analyst Firm	Price Target Change	Rating Change	Previous / Current Rating
12/22/2022	—	Oppenheimer		Downgrades	Outperform → Perform
09/12/2022	290.62%	Morgan Stanley	$8 → $5	Maintains	Equal-Weight
08/25/2022	1071.87%	Alliance Global Partners	→ $15	Initiates Coverage On	→ Buy
08/23/2022	368.75%	Truist Securities	$10 → $6	Maintains	Hold
06/22/2022	1071.87%	HC Wainwright & Co.	→ $15	Initiates Coverage On	→ Buy
04/06/2022	—	Truist Securities		Downgrades	Buy → Hold
01/28/2022	603.12%	Oppenheimer	→ $9	Initiates Coverage On	→ Outperform
11/24/2021	603.12%	Morgan Stanley	→ $9	Initiates Coverage On	→ Equal-Weight
10/19/2021	837.5%	Truist Securities	→ $12	Initiates Coverage On	→ Buy

日期	上行/下行	分析公司	目标价格变化	评级变化	上一次/当前评级
12/22/2022	—	奥本海默		评级下调	超越→表现
09/12/2022	290.62%	摩根士丹利	$8 → $5	维护	等重
08/25/2022	1071.87%	联盟全球合作伙伴	→ $15	开始承保	→购买
08/23/2022	368.75%	Truist证券	$10 → $6	维护	保持
06/22/2022	1071.87%	HC Wainwright公司	→ $15	开始承保	→购买
04/06/2022	—	Truist证券		评级下调	购买→Hold
01/28/2022	603.12%	奥本海默	→ $9	开始承保	→跑赢大盘
11/24/2021	603.12%	摩根士丹利	→ $9	开始承保	→等重
10/19/2021	837.5%	Truist证券	→ $12	开始承保	→购买

There is no price target for Celularity

Celulity没有目标价格

There is no analyst for Celularity

赛卢拉蒂没有分析员

There is no next analyst rating for Celularity

Celularis没有下一个分析师评级

There is no next analyst rating for Celularity

Celularis没有下一个分析师评级

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

风险及免责提示